Avalo Therapeutics Inc (AVTX) Rapporto sugli Utili - Previsioni e Surprise Ratio

Pubblicita'

Storico dei ricavi trimestrali

Data del prossimo reportMay 16, 2024

Stimato per Q2 24:$-1.18

Cambiamenti implicati per il Q1 24:-95.49%

Cambiamenti implicati per il Q2 23:-99.52%

Periodo Bilanci	Data Riportata	EPS / Previsioni	Sorpresa
Q1 24	May 13, 2024	$-5.98 / $-1.18	$-4.8 / -406.78%
Q3 23	Nov 9, 2023	$-26.19 / $-261.9	$235.71 / 90%
Q2 23	Aug 3, 2023	$-140.48 / $-214.29	$73.81 / 34.44%
Q1 23	May 4, 2023	$-202.38 / $-230.95	$28.57 / 12.37%
Q4 22	Mar 29, 2023	$-247.62 / $-123.81	$-123.81 / -100%
Q3 22	Nov 7, 2022	$80.95 / $-245.24	$326.19 / 133.01%
Q2 22	Aug 4, 2022	$-328.57 / $-428.57	$100 / 23.33%
Q1 22	May 5, 2022	$-571.66 / $-400.16	$-171.5 / -42.86%

Fornitori di Dati: Xignite Logo